Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Amortization of intangible assets unassociated with by Quarter
Amortization of intangible assets unassociated with segments ($M) ($M)
Pfizer Amortization of intangible assets unassociated with: $1,185M in Q2 2026, down 2.1% from a year earlier.
Latest, Q2 2026
1,185
Period ended Jun 28, 2026
Change on a year earlier
-2.1%
1,211 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Consolidated Statement of Income.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Amortization of intangible assets unassociated with segments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 1,185 | -2.1% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 1,183 | -2.3% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,230 | -9.5% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 1,223 | -6.8% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 1,211 | -7.3% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 30, 2025 | 1,211 | -7.4% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,359 | +7.3% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 1,312 | +11.3% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,307 | +10.4% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,308 | +18.6% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,267 | +12.0% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2023 | Oct 1, 2023 | 1,179 | +43.4% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 1,184 | +44.0% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | 1,103 | +32.1% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,131 | +18.2% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2022 | Oct 2, 2022 | 822 | -15.1% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2022 | Jul 3, 2022 | 822 | -10.4% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2022 | Apr 3, 2022 | 835 | -2.7% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2021 | Dec 31, 2021 | 957 | +24.4% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2021 | Oct 3, 2021 | 968 | +12.3% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | 917 | +5.5% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | 858 | +1.1% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | 769 | -9.6% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2020 | Sep 27, 2020 | 862 | -28.9% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | 869 | -26.6% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 849 | -28.2% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2019 | Dec 31, 2019 | 851 | -22.4% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2019 | Sep 29, 2019 | 1,212 | -3.3% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,184 | -0.6% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,183 | -1.1% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,096 | -7.7% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2018 | Sep 30, 2018 | 1,253 | +6.5% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2018 | Jul 1, 2018 | 1,191 | -1.4% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Apr 1, 2018 | 1,196 | +0.8% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 1,187 | – | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2017 | Oct 1, 2017 | 1,177 | – | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2017 | Jul 2, 2017 | 1,208 | – | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2017 | Apr 2, 2017 | 1,186 | – | Form 10-Q (filed 2018-05-10) ↗ |
Cite this data
StockData. (2026). Pfizer Amortization of intangible assets unassociated with ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/amort-unassoc
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.